[Skip to Navigation]
Invited Commentary
May 2017

Good News for Screening for Adult Attention-Deficit/Hyperactivity Disorder

Author Affiliations
  • 1Social and Behavioral Research Branch, National Human Genome Research Institute, Bethesda, Maryland
  • 2Child Psychiatry Branch, National Institute of Mental Health, Bethesda, Maryland
JAMA Psychiatry. 2017;74(5):527. doi:10.1001/jamapsychiatry.2017.0296

Adult attention-deficit/hyperactivity disorder (ADHD) was a rare diagnosis 30 years ago, but epidemiological studies in the 2000s estimated a prevalence between 2% and 5%.1 More recent reports suggest there may be a rapid increase in new diagnoses, much as has been found for childhood ADHD.2 Changes to diagnostic criteria in DSM-5 (compared with DSM-IV) are likely to lead to further increases. These include lowering the number of symptoms for diagnosis in adults from 6 to 5 and raising the age at onset of childhood symptoms from 7 years to 12 years. Additionally, there has been a switch from an emphasis on clinically significant impairment in DSM-IV to the more lenient requirement that symptoms “interfere” or “lower quality” of day-to-day functioning.

Add or change institution